ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 6 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $210,513 | -20.2% | 20,068 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $263,694 | +12.8% | 20,068 | +8.1% | 0.00% | 0.0% |
Q2 2023 | $233,869 | +19.0% | 18,561 | +23.3% | 0.00% | 0.0% |
Q1 2023 | $196,494 | -26.2% | 15,057 | -0.2% | 0.00% | 0.0% |
Q4 2022 | $266,117 | +15.7% | 15,086 | -0.3% | 0.00% | 0.0% |
Q3 2022 | $230,000 | -46.0% | 15,133 | -47.3% | 0.00% | -50.0% |
Q2 2022 | $426,000 | +10.6% | 28,714 | +67.8% | 0.00% | 0.0% |
Q1 2022 | $385,000 | +21.8% | 17,113 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $316,000 | +38.0% | 17,113 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $229,000 | -27.8% | 17,113 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $317,000 | +1.0% | 17,113 | -18.2% | 0.00% | 0.0% |
Q1 2021 | $314,000 | -6.8% | 20,911 | -10.5% | 0.00% | 0.0% |
Q4 2020 | $337,000 | +104.2% | 23,372 | +15.1% | 0.00% | +100.0% |
Q3 2020 | $165,000 | +20.4% | 20,307 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $137,000 | +55.7% | 20,307 | +63.0% | 0.00% | 0.0% |
Q1 2020 | $88,000 | -27.9% | 12,460 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $122,000 | -10.9% | 12,460 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $137,000 | -5.5% | 12,460 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $145,000 | +42.2% | 12,460 | +16.9% | 0.00% | 0.0% |
Q1 2019 | $102,000 | -77.5% | 10,660 | -77.3% | 0.00% | -80.0% |
Q4 2018 | $454,000 | -31.6% | 47,053 | +1.0% | 0.01% | -16.7% |
Q3 2018 | $664,000 | +18.8% | 46,584 | 0.0% | 0.01% | +20.0% |
Q2 2018 | $559,000 | -2.8% | 46,584 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $575,000 | -15.2% | 46,584 | 0.0% | 0.01% | -16.7% |
Q4 2017 | $678,000 | +30.1% | 46,584 | +27.2% | 0.01% | +20.0% |
Q3 2017 | $521,000 | +478.9% | 36,627 | +418.1% | 0.01% | +400.0% |
Q2 2017 | $90,000 | -25.0% | 7,069 | -25.1% | 0.00% | 0.0% |
Q1 2017 | $120,000 | +36.4% | 9,434 | +9.5% | 0.00% | 0.0% |
Q4 2016 | $88,000 | -22.1% | 8,618 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $113,000 | +27.0% | 8,618 | +23.3% | 0.00% | 0.0% |
Q2 2016 | $89,000 | +21.9% | 6,992 | +27.3% | 0.00% | 0.0% |
Q1 2016 | $73,000 | -13.1% | 5,492 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $84,000 | +281.8% | 5,492 | +209.1% | 0.00% | – |
Q3 2015 | $22,000 | +144.4% | 1,777 | +174.2% | 0.00% | – |
Q2 2015 | $9,000 | +12.5% | 648 | 0.0% | 0.00% | – |
Q1 2015 | $8,000 | -63.6% | 648 | -71.8% | 0.00% | -100.0% |
Q4 2012 | $22,000 | -87.4% | 2,300 | -83.7% | 0.00% | -85.7% |
Q3 2012 | $175,000 | -76.5% | 14,069 | -79.3% | 0.01% | -78.8% |
Q2 2012 | $744,000 | -28.0% | 68,069 | +9.3% | 0.03% | -29.8% |
Q1 2012 | $1,034,000 | -44.9% | 62,300 | -37.2% | 0.05% | -45.3% |
Q4 2011 | $1,878,000 | – | 99,139 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |